TrialJAMA2022

Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.

Steven E Nissen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.